so maybe $500 plus per treatment , half for virbac half for qbiotics , so above numbers stand up'ish. pop a PE of 10 on this annual revenue of $190 million = company value $1900million. 390million shares = $4.90/share ( US figures only )
- Forums
- ASX - By Stock
- Qbiotics
so maybe $500 plus per treatment , half for virbac half for...
-
- There are more pages in this discussion • 1,125 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online